Liangbin Lin

Third People's Hospital of Chengdu — China

Medicine · Health Sciences

6h-index2.2kcitations20works6.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ferroptosis and cancer prognosis(5), Immune Cell Function and Interaction(4), Immune cells in cancer(4), interferon and immune responses(4), Glioma Diagnosis and Treatment(3)

Publications20 total

FAM-related prognostic molecular subtype screening identified epithelial-derived MAOA-inhibiting bladder cancer
Frontiers in Cell and Developmental Biology·2026Open Access
A novel tumor-progressing fibroblast signature derived from single-cell RNA sequencing enables prognostic stratification and reveals RNF11 as a functional regulator in bladder cancer
Frontiers in Molecular Biosciences·2026Open Access
A novel prognostic model based on epithelial cell progression genes identifies OAS1 as a suppressor of bladder cancer aggressiveness
Frontiers in Molecular Biosciences·2026Open Access
Single-cell analysis of human thymus and peripheral blood unveils the dynamics of T cell development and aging
Nature Aging·2025· 5 cited
Effect of Low Nighttime Temperature on Oil Accumulation of Rapeseed Seeds (Brassica napus L.) Based on RNA-Seq of Silique Wall Tissue
Agriculture·2025Open Access
Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy
Frontiers in Cell and Developmental Biology·2024· 17 citedOpen Access
Systemic lupus erythematosus: pathogenesis and targeted therapy
Molecular Biomedicine·2024· 34 citedOpen Access
Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas
Scientific Reports·2024· 3 citedOpen Access
Mechanism study of ubiquitination in T cell development and autoimmune disease
Frontiers in Immunology·2024· 5 citedOpen Access
Identification of EMT-associated prognostic features among grade II/III gliomas
Scientific Reports·2024· 6 citedOpen Access
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome
American Journal of Cancer Research·2024· 1 citedOpen Access
Comment on “An Injectable Hydrogel to Modulate <i>T</i> Cells for Cancer Immunotherapy”
Small·2023· 2 cited
TRIM55 promotes noncanonical NF-κB signaling and B cell–mediated immune responses by coordinating p100 ubiquitination and processing
Science Signaling·2023· 15 cited
Transcriptomic Profiling of Shoot Apical Meristem Aberrations in the Multi-Main-Stem Mutant (ms) of Brassica napus L.
Genes·2023· 1 citedOpen Access
Leveraging a diverse cell-death patterns-based signature to predict the prognosis of low- grade gliomas
Research Square (Research Square)·2023Open Access
Cytokinin Signaling Are Required for Multi-Main Stems Development in &lt;em&gt;Brassica napus&lt;/em&gt; L.
Preprints.org·2023· 3 citedOpen Access
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Signal Transduction and Targeted Therapy·2020· 1.9k citedOpen Access
Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy
Frontiers in Immunology·2019· 59 citedOpen Access
Author Correction to: TRIM29 negatively controls antiviral immune response through targeting STING for degradation
Cell Discovery·2018· 3 citedOpen Access
TRIM29 negatively controls antiviral immune response through targeting STING for degradation
Cell Discovery·2018· 139 citedOpen Access

Frequent Co-authors

Wenyong Yang(9), Huiyuan Zhang(6), Hongbo Hu(6), Qingqiang Lei(6), Hui Yu(4), Xuerui Chen(4), Yanli Tong(3), Yanqiu Gong(3), Yi Zhao(3), Lunzhi Dai(3), Yuanbiao Guo(3), Hui Zhuo(3), Chao Mi(3), Miaoyu Zhang(3), Xu Su(3), Qijie Li(2), Yantong Liu(2), Jun Mou(2), Xiuxuan Wang(2), Yi Liu(2)